59 related articles for article (PubMed ID: 1312474)
21. Interleukin-6 receptor and a unique mechanism of its signal transduction.
Taga T; Hibi M; Hirata Y; Yawata H; Natsuka S; Yasukawa K; Totsuka T; Yamasaki K; Hirano T; Kishimoto T
Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():713-22. PubMed ID: 2640626
[No Abstract] [Full Text] [Related]
22. A monoclonal antibody specific for the murine IL-6-receptor inhibits the growth of a mouse plasmacytoma in vivo.
Coulie PG; Vink A; Van Snick J
Curr Top Microbiol Immunol; 1990; 166():43-6. PubMed ID: 2073815
[No Abstract] [Full Text] [Related]
23. [IL-6 and IL-6 receptor].
Murakami M; Hirano T
Seikagaku; 1990 Jan; 62(1):32-5. PubMed ID: 2181039
[No Abstract] [Full Text] [Related]
24. Interleukin 6 in infection and cancer.
Sehgal PB
Proc Soc Exp Biol Med; 1990 Nov; 195(2):183-91. PubMed ID: 2236101
[No Abstract] [Full Text] [Related]
25. Interleukin-6: an overview.
Van Snick J
Annu Rev Immunol; 1990; 8():253-78. PubMed ID: 2188664
[No Abstract] [Full Text] [Related]
26. Interleukin-6 in biology and medicine.
Akira S; Taga T; Kishimoto T
Adv Immunol; 1993; 54():1-78. PubMed ID: 8379461
[No Abstract] [Full Text] [Related]
27. Interleukin 6 (IL-6).
Matsuda T; Hirano T
Biotherapy; 1990; 2(4):363-73. PubMed ID: 2268501
[No Abstract] [Full Text] [Related]
28. IL6 and the acute phase reaction.
Gauldie J; Richards C; Baumann H
Res Immunol; 1992 Sep; 143(7):755-9. PubMed ID: 1439151
[No Abstract] [Full Text] [Related]
29. The RhoU/Wrch1 Rho GTPase gene is a common transcriptional target of both the gp130/STAT3 and Wnt-1 pathways.
Schiavone D; Dewilde S; Vallania F; Turkson J; Di Cunto F; Poli V
Biochem J; 2009 Jun; 421(2):283-92. PubMed ID: 19397496
[TBL] [Abstract][Full Text] [Related]
30. Construction and characterization of a replication-deficient adenovirus expressing rat-soluble interleukin-6 receptor.
Thibault V; Terlain B; Graham FL; Gauldie J
Mol Med; 1997 Aug; 3(8):519-29. PubMed ID: 9307980
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?
Biffl WL; Moore EE; Moore FA; Peterson VM
Ann Surg; 1996 Nov; 224(5):647-64. PubMed ID: 8916880
[TBL] [Abstract][Full Text] [Related]
32. Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.
Toniatti C; Cabibbo A; Sporena E; Salvati AL; Cerretani M; Serafini S; Lahm A; Cortese R; Ciliberto G
EMBO J; 1996 Jun; 15(11):2726-37. PubMed ID: 8654370
[TBL] [Abstract][Full Text] [Related]
33. Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation.
Savino R; Lahm A; Salvati AL; Ciapponi L; Sporeno E; Altamura S; Paonessa G; Toniatti C; Ciliberto G
EMBO J; 1994 Mar; 13(6):1357-67. PubMed ID: 7511100
[TBL] [Abstract][Full Text] [Related]
34. Expression of the murine interleukin 6 receptor in hepatoma cells: the intracytoplasmic domain is not required for interleukin 6 signal transduction.
Fiorillo MT; Toniatti C; Van Snick J; Ciliberto G
Eur J Immunol; 1992 Mar; 22(3):799-804. PubMed ID: 1312474
[TBL] [Abstract][Full Text] [Related]
35. Molecular cloning, characterization and functional expression of the rat liver interleukin 6 receptor.
Baumann M; Baumann H; Fey GH
J Biol Chem; 1990 Nov; 265(32):19853-62. PubMed ID: 2174054
[TBL] [Abstract][Full Text] [Related]
36. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth.
Vigon I; Florindo C; Fichelson S; Guenet JL; Mattei MG; Souyri M; Cosman D; Gisselbrecht S
Oncogene; 1993 Oct; 8(10):2607-15. PubMed ID: 8397366
[TBL] [Abstract][Full Text] [Related]
38. Interleukin 6/interleukin 6 receptor interaction and its role as a therapeutic target for treatment of cachexia and cancer.
Weidle UH; Klostermann S; Eggle D; Krüger A
Cancer Genomics Proteomics; 2010; 7(6):287-302. PubMed ID: 21156962
[TBL] [Abstract][Full Text] [Related]
39. IL6 signalling through IL6 receptor and receptor-associated signal transducer, gp130.
Taga T
Res Immunol; 1992 Sep; 143(7):737-9. PubMed ID: 1439146
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
